Aldosterone blockade and heart failure

被引：19

作者：

Jessup, M ^{[1
]}

机构：

[1] Univ Penn, Dept Med, Div Cardiovasc Med, Philadelphia, PA 19104 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2003年 / 348卷 / 14期

关键词：

D O I：

10.1056/NEJMe030030

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1380 / 1382

页数：4

共 10 条

[1] Complications of inappropriate use of spiroholactone in heart failure: When an old medicine spirals out of new guidelines [J].

Bozkurt, B ;

Agoston, I ;

Knowlton, AA .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (02) :211-214

[2] Long-term, dose-dependent effects of spironolactone on left ventricular function and exercise tolerance in patients with chronic heart failure [J].

Cicoira, M ;

Zanolla, L ;

Rossi, A ;

Golia, G ;

Franceschini, L ;

Brighetti, G ;

Marino, P ;

Zardini, P .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (02) :304-310

[3] ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) [J].

Hunt, SA ;

Baker, DW ;

Chin, MH ;

Cinquegrani, MP ;

Feldman, AM ;

Francis, GS ;

Ganiats, TG ;

Goldstein, S ;

Gregoratos, G ;

Jessup, ML ;

Noble, RJ ;

Packer, M ;

Silver, MA ;

Stevenson, LW ;

Gibbons, RJ ;

Antman, EM ;

Alpert, JS ;

Faxon, DP ;

Fuster, V ;

Gregoratos, G ;

Jacobs, AK ;

Hiratzka, LF ;

Russell, RO ;

Smith, SC .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (07) :2101-2113

[4] New therapeutic options in congestive heart failure: Part I [J].

McMurray, J ;

Pfeffer, MA .

CIRCULATION, 2002, 105 (17) :2099-2106

[5] Shattuck lecture - Hidden barriers to improvement in the quality of care [J].

McNeil, BJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1612-1620

[6] Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction [J].

Pitt, B ;

Remme, W ;

Zannad, F ;

Neaton, J ;

Martinez, F ;

Roniker, B ;

Bittman, R ;

Hurley, S ;

Kleiman, J ;

Gatlin, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1309-1321

[7] The effect of spironolactone on morbidity and mortality in patients with severe heart failure [J].

Pitt, B ;

Zannad, F ;

Remme, WJ ;

Cody, R ;

Castaigne, A ;

Perez, A ;

Palensky, J ;

Wittes, J .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :709-717

[8]

Struthers Allan D, 2002, Congest Heart Fail, V8, P18, DOI 10.1111/j.1527-5299.2002.00722.x

[9] Aldosterone and spironolactone in heart failure [J].

Weber, KT .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (10) :753-755

[10] Mechanisms of disease - Aldosterone in congestive heart failure [J].

Weber, KT .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (23) :1689-1697

← 1 →